141 related articles for article (PubMed ID: 33337372)
21. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
22. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
23. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
24. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
[TBL] [Abstract][Full Text] [Related]
25. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue.
Ni R; Röjdner J; Voytenko L; Dyrks T; Thiele A; Marutle A; Nordberg A
J Alzheimers Dis; 2021; 80(4):1723-1737. PubMed ID: 33749648
[TBL] [Abstract][Full Text] [Related]
26. Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions.
Serrano GE; Sabbagh MN; Sue LI; Hidalgo JA; Schneider JA; Bedell BJ; Van Deerlin VM; Suh E; Akiyama H; Joshi AD; Pontecorvo MJ; Mintun MA; Beach TG
J Alzheimers Dis; 2014; 42(3):813-21. PubMed ID: 24927705
[TBL] [Abstract][Full Text] [Related]
27. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
28. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
Landau SM; Fero A; Baker SL; Koeppe R; Mintun M; Chen K; Reiman EM; Jagust WJ
J Nucl Med; 2015 Apr; 56(4):567-74. PubMed ID: 25745095
[TBL] [Abstract][Full Text] [Related]
29. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
30. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
[TBL] [Abstract][Full Text] [Related]
31. Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy.
Wu KY; Lin KJ; Chen CH; Chen CS; Liu CY; Huang SY; Yen TC; Hsiao IT
Brain Behav; 2018 Jul; 8(7):e01016. PubMed ID: 29927088
[TBL] [Abstract][Full Text] [Related]
32. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
[TBL] [Abstract][Full Text] [Related]
33. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
34. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
[TBL] [Abstract][Full Text] [Related]
35. Amyloid burden in the hippocampus and default mode network: relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease.
Chang YT; Huang CW; Chang YH; Chen NC; Lin KJ; Yan TC; Chang WN; Chen SF; Lui CC; Lin PH; Chang CC
Medicine (Baltimore); 2015 Apr; 94(16):e763. PubMed ID: 25906109
[TBL] [Abstract][Full Text] [Related]
36. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
Lister-James J; Pontecorvo MJ; Clark C; Joshi AD; Mintun MA; Zhang W; Lim N; Zhuang Z; Golding G; Choi SR; Benedum TE; Kennedy P; Hefti F; Carpenter AP; Kung HF; Skovronsky DM
Semin Nucl Med; 2011 Jul; 41(4):300-4. PubMed ID: 21624563
[TBL] [Abstract][Full Text] [Related]
37. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.
Hanko V; Apple AC; Alpert KI; Warren KN; Schneider JA; Arfanakis K; Bennett DA; Wang L
Neurobiol Aging; 2019 Feb; 74():171-181. PubMed ID: 30453234
[TBL] [Abstract][Full Text] [Related]
38. Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages.
Pereira JB; Strandberg TO; Palmqvist S; Volpe G; van Westen D; Westman E; Hansson O;
Cereb Cortex; 2018 Jan; 28(1):340-349. PubMed ID: 29136123
[TBL] [Abstract][Full Text] [Related]
39. No Association of Lower Hippocampal Volume With Alzheimer's Disease Pathology in Late-Life Depression.
De Winter FL; Emsell L; Bouckaert F; Claes L; Jain S; Farrar G; Billiet T; Evers S; Van den Stock J; Sienaert P; Obbels J; Sunaert S; Adamczuk K; Vandenberghe R; Van Laere K; Vandenbulcke M
Am J Psychiatry; 2017 Mar; 174(3):237-245. PubMed ID: 27539488
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.
Nag S; Yu L; Capuano AW; Wilson RS; Leurgans SE; Bennett DA; Schneider JA
Ann Neurol; 2015 Jun; 77(6):942-52. PubMed ID: 25707479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
